Wafik S. El-Deiry: Lobbying congress to make cancer funding a priority

Wafik S. El-Deiry shared a post on Linkedin:

” I am reminded of the first time I went to advocate for NIH funding in 2006. I’ll share this editorial I wrote about the experience so that more of my colleagues step up and become more active for change.

Many issues have not changed in nearly 20 years but I do believe that some day the government will listen and more highly prioritize research funding in the US.

Lobbying congress to make cancer funding a priority: What scientists can do.”

Lobbying congress to make cancer funding a priority: What scientists can do

Author: Wafik S. El-Deiry

Additional information.
Source: Wafik S. El-Deiry/Linkedin

Wafik S. El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals. He is the Editor in Chief at Oncotarget. Dr. El-Deiry discovered p21(WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response. Dr. El-Deiry’s research is focused on mechanisms of therapy resistance with major efforts in drug discovery and development.